Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients

Journal of Human Hypertension volume 32, pages 564–571 (2018)Cite this article

Subjects

Abstract

Recent research suggested that certain small leucine-rich repeat proteoglycans (SLRPs) were involved in the development of atherosclerosis. The present study investigated the relationship between carotid atherosclerosis plaque and the circulating levels of some SLRPs, including decorin, lumican, and osteoglycin, in essential hypertension. In total, 176 essential hypertensive patients were recruited (mean age 62.1 ± 9.4, male 56.8%) in this study and were classified into two groups: patients with carotid artery plaque (n = 105, 60%) and patients without carotid artery plaque (n = 71, 40%). Patients with carotid artery plaque had higher serum concentration of lumican than patients without carotid plaque (58.0 ± 1.6 vs. 52.3 ± 2.1 ng/ml, p = 0.04) after adjusting for conventional cardiovascular risk factors. There were no differences in decorin and osteoglycin between the two groups. Multivariable logistic regression analysis revealed that lumican levels (Odds ratio (OR) per standard deviation increase, 1.598; 95% confidence interval (CI), 1.012 ~ 2.523; p = 0.04), 24-h mean systolic blood pressure (OR, 1.045; 95% CI, 1.012 ~ 1.079; p = 0.006) and the use of angiotensin receptor blocker (OR, 2.813; 95% CI, 1.023 ~ 7.734; p = 0.045) were independently associated with carotid artery plaque. Besides carotid artery plaque, lumican was related to impaired glucose tolerance (r = 0.162, p = 0.046) and adversely related to osteoglycin (r = − 0.273, p < 0.001), whereas unrelated to age, sex, BMI, diabetes, blood pressure, serum lipids, high-sensitivity C-reactive protein, or carotid intima-media thickness in univariate correlation analyses. Circulating lumican was independently associated with carotid atherosclerosis plaque in essential hypertensive patients, indicating that SLRPs might be used as a promising molecular marker for atherosclerosis.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010;55:1600–7.

    Article  CAS  Google Scholar 

  2. Tattersall MC, Gassett A, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, et al. Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis. Stroke. 2014;45:3257–62.

    Article  Google Scholar 

  3. Belcaro G, Nicolaides AN, Ramaswami G, Cesarone MR, De Sanctis M, Incandela L, et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risksubjects: a 10-year follow-up study (the CAFES-CAVE study 1). Atherosclerosis. 2001;156:379–87.

    Article  CAS  Google Scholar 

  4. Onda M, Ishiwata T, Kawahara K, Wang R, Naito Z, Sugisaki Y. Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Exp Mol Pathol. 2002;72:142–9.

    Article  CAS  Google Scholar 

  5. Shami A, Tengryd C, Asciutto G, Bengtsson E, Nilsson J, Hultgårdh-Nilsson A, et al. Expression of fibromodulin in carotid atherosclerotic plaques is associated with diabetes and cerebrovascular events. Atherosclerosis. 2015;241:701–8.

    Article  CAS  Google Scholar 

  6. Fernández B, Kampmann A, Pipp F, Zimmermann R, Schaper W. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol Cell Biochem. 2003;246:3–11.

    Article  Google Scholar 

  7. Shen Y, Ding FH, Zhang RY, Zhang Q, Lu L, Shen WF. Association of serum mimecan with angiographic coronary collateralization in patients with stable coronary artery disease and chronic total occlusion. Atherosclerosis. 2016;252:75–81.

    Article  CAS  Google Scholar 

  8. Gu X, Zhao L, Zhu J, Gu H, Li H, Wang L, et al. Serum Mimecan is associated with arterial stiffness in hypertensive patients. J Am Heart Assoc. 2015;4:e002010.

    Article  Google Scholar 

  9. Ström A, Ahlqvist E, Franzén A, Heinegård D, Hultgårdh-Nilsson A. Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: an immunohistochemical study. Histol Histopathol. 2004;19:337–47.

    PubMed  Google Scholar 

  10. Merrilees MJ, Beaumont B, Scott LJ. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron Artery Dis. 2001;12:7–16.

    Article  CAS  Google Scholar 

  11. Ranjzad P, Salem HK, Kingston PA. Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease. Gene Ther. 2009;16:1154–62.

    Article  CAS  Google Scholar 

  12. Joint committee issued Chinese guideline for the management of dyslipidemia in adults. 2016 Chinese guideline for the management of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44:833–53.

    Google Scholar 

  13. Health management branch, Ultrasound medicine branch and Cardiology branch of Chinese Medical Association, editorial board of Chinese Journal of Health Management. The standard of carotid ultrasound examination for Chinese healthy population. Chin J Health Manag. 2015;9:254–60.

    Google Scholar 

  14. American Institute of Ultrasound in Medicine. AIUM practice parameter for the performance of an ultrasound examination of the extracranial cerebrovascular system. J Ultrasound Med. 2016;35:1–11.

    Article  Google Scholar 

  15. Bubenek S, Nastase A, Niculescu AM, Baila S, Herlea V, Lazar V, et al. Assessment of gene expression profiles in peripheral occlusive arterial disease. Can J Cardiol. 2012;28:712–20.

    Article  Google Scholar 

  16. Martin-Rojas T, Gil-Dones F, Lopez-Almodovar LF, Padial LR, Vivanco F, Barderas MG. Proteomic profile of human aortic stenosis: insights into the degenerative process. J Proteome Res. 2012;11:1537–50.

    Article  CAS  Google Scholar 

  17. Wu F, Vij N, Roberts L, Lopez-Briones S, Joyce S, Chakravarti S. A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response. J Biol Chem. 2007;282:26409–17.

    Article  CAS  Google Scholar 

  18. Vij N, Roberts L, Joyce S, Chakravarti S. Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest Ophthalmol Vis Sci. 2005;6:88–95.

    Article  Google Scholar 

  19. Lohr K, Sardana H, Lee S, Wu F, Huso DL, Hamad AR, et al. Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis. Inflamm Bowel Dis. 2012;18:143–51.

    Article  Google Scholar 

  20. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol. 2000;151:779–88.

    Article  CAS  Google Scholar 

  21. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998;141:1277–86.

    Article  CAS  Google Scholar 

  22. Cheng JM, Akkerhuis KM, Meilhac O, Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, et al. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography. Arterioscler Thromb Vasc Biol. 2014;34:1078–84.

    Article  CAS  Google Scholar 

  23. Moncayo-Arlandi J, López-García A, Fernández MC, Durán AC, Fernández B. Osteoglycin deficiency does not affect atherosclerosis in mice. Atherosclerosis. 2014;237:418–25.

    Article  CAS  Google Scholar 

  24. Xu YZ, Zhao KJ, Yang ZG, Zhang YH, Zhang YW, Hong B, et al. Decreased plasma decorin levels following acute ischemic stroke: correlation with MMP-2 and differential expression in TOAST subtypes. Mol Med Rep. 2012;6:1319–24.

    Article  CAS  Google Scholar 

  25. Al Haj Zen A, Caligiuri G, Sainz J, Lemitre M, Demerens C, Lafont A. Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice. Atherosclerosis. 2006;187:31–9.

    Article  CAS  Google Scholar 

  26. Tasheva ES, Klocke B, Conrad GW. Analysis of transcriptional regulation of the small leucine rich proteoglycans. Mol Vis. 2004;10:758e72.

    Google Scholar 

  27. Hultgårdh-Nilsson A, Borén J, Chakravarti S. The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. J Intern Med. 2015;278:447–61.

    Article  Google Scholar 

  28. Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res. 2012;111:245–59.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81400179), General Program of Shanghai Municipal Health and Family Planning Commission (201440530), Science and Technology Fund Project of Shanghai Jiao Tong University School of Medicine (14XJ10070). We gratefully acknowledge the support of Shanghai Jiao Tong University K.C. Wong Medical Fellowship fund.

Author information

Authors and Affiliations

  1. Shanghai Key Laboratory of Vascular Biology, State Key Laboratory of Medical Genomics, Shanghai, China

    Yan Yang, Qi-hong Wu, Yan Li & Ping-jin Gao

  2. Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

    Yan Yang, Qi-hong Wu, Yan Li & Ping-jin Gao

  3. Laboratory of Vascular Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China

    Ping-jin Gao

Authors
  1. Yan Yang
    View author publications

    Search author on:PubMed Google Scholar

  2. Qi-hong Wu
    View author publications

    Search author on:PubMed Google Scholar

  3. Yan Li
    View author publications

    Search author on:PubMed Google Scholar

  4. Ping-jin Gao
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Ping-jin Gao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Wu, Qh., Li, Y. et al. Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients. J Hum Hypertens 32, 564–571 (2018). https://doi.org/10.1038/s41371-018-0077-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41371-018-0077-7

This article is cited by

Search

Advanced search

Quick links